Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modeling drug-induced liver injury and screening for anti-hepatofibrotic compounds using human PSC-derived organoids
Xiaoshan Wu, Dacheng Jiang, Yi Yang, et al.
Cell Regeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 18

Showing 18 citing articles:

Landscape of human organoids: Ideal model in clinics and research
Xinxin Han, Chunhui Cai, Wei Deng, et al.
The Innovation (2024) Vol. 5, Iss. 3, pp. 100620-100620
Open Access | Times Cited: 32
Organoids and organoids-on-a-chip as the new testing strategies for environmental toxicology-applications & advantages
Chengyu Hu, Sheng Yang, Tianyi Zhang, et al.
Environment International (2024) Vol. 184, pp. 108415-108415
Open Access | Times Cited: 18
Organoid-guided precision hepatology for metabolic liver disease
Sho Osonoi, Takanori Takebe
Journal of Hepatology (2024) Vol. 80, Iss. 5, pp. 805-821
Closed Access | Times Cited: 11
Evaluating the synergistic use of advanced liver models and AI for the prediction of drug-induced liver injury
Yitian Zhou, Yi Zhong, Volker M. Lauschke
Expert Opinion on Drug Metabolism & Toxicology (2025), pp. 1-15
Closed Access | Times Cited: 1
Revealing the clinical potential of high-resolution organoids
Jihoon Ko, Sujin Hyung, Sunghun Cheong, et al.
Advanced Drug Delivery Reviews (2024) Vol. 207, pp. 115202-115202
Closed Access | Times Cited: 6
Patient-derived induced pluripotent stem cell organoids for amyotrophic lateral sclerosis drug discovery
Wenyan Li, Jinqi Liu, Wenting Li, et al.
Acta Materia Medica (2025) Vol. 4, Iss. 1
Open Access
Celastrol reduces cisplatin-induced nephrotoxicity by downregulating SNORD3A level in kidney organoids derived from human iPSCs
Chia‐Ning Shen, Qizheng Wang, Xun Ye, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Bavachinin causes cholestasis by down-regulating BAAT expression and disrupting glycocholic acid synthesis in human liver organoids
Xue Wang, Su Jeong Yu, Xiaomeng Chen, et al.
Food and Chemical Toxicology (2025), pp. 115438-115438
Closed Access
Challenges of in vitro modelling of liver fibrosis
Patricia Ros-Tárraga, Estela Villanueva-Bádenas, Estela Sanchez-Gonzalez, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Human Hepatobiliary Organoids: Recent Advances in Drug Toxicity Verification and Drug Screening
H. Fang, Haoying Xu, Jiong Yu, et al.
Biomolecules (2024) Vol. 14, Iss. 7, pp. 794-794
Open Access | Times Cited: 3
Current Treatment Regimens and Promising Molecular Therapies for Chronic Hepatobiliary Diseases
Marilena Durazzo, Arianna Ferro, Victor Navarro‐Tableros, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 121-121
Open Access
An Overview on Spheroid and Organoid Models in Applied Studies
Zorislava Živković, Teuta Opačak‐Bernardi
Sci (2025) Vol. 7, Iss. 1, pp. 27-27
Open Access
From gut to liver: organoids as platforms for next-generation toxicology assessment vehicles for xenobiotics
Sulaiman Mohammed Alnasser
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access
Hepatic organoids move from adolescence to maturity
Yuan Guan, Gary Peltz
Liver International (2024) Vol. 44, Iss. 6, pp. 1290-1297
Open Access | Times Cited: 2
Molecular Mechanisms of Fibrosis in Cholestatic Liver Diseases and Regenerative Medicine-Based Therapies
Weilu Wang, Huibin Lian, Yingyu Liang, et al.
Cells (2024) Vol. 13, Iss. 23, pp. 1997-1997
Open Access | Times Cited: 2
The Current Proceedings of PSC-Based Liver Fibrosis Therapy
Ma Li, Qiang Wu, Paul Kwong‐Hang Tam
Stem Cell Reviews and Reports (2023) Vol. 19, Iss. 7, pp. 2155-2165
Closed Access | Times Cited: 2
Fibrotic Phenotype in CRISPR knockout p53 of Hepatic Organoids within a Pro-Carcinogenic Microenvironment
Esra Erdal, Mustafa Karabicici, Soheil Akbari, et al.
Research Square (Research Square) (2024)
Open Access
Modeling metabolic-associated steatohepatitis with human pluripotent stem cell-derived liver organoids
Xiaoshan Wu, Dacheng Jiang, Yuchen Wang, et al.
Hepatology Communications (2024) Vol. 8, Iss. 12
Open Access
Page 1

Scroll to top